4.6 Review

Statin Use and the Risk of Prostate Cancer Biochemical Recurrence Following Definitive Therapy: A Systematic Review and Meta-Analysis of Cohort Studies

Related references

Note: Only part of the references are listed.
Article Endocrinology & Metabolism

Metabolic syndrome and prostate cancer in Afro-Caribbean men

Florian Lefebvre et al.

Summary: This study aimed to assess the prevalence of metabolic syndrome among Afro-Caribbean prostate cancer patients and its association with adverse clinicopathological features and biochemical recurrence risk. The results showed a high variability in metabolic syndrome prevalence depending on the obesity criteria used, and no significant association was found between metabolic syndrome and prostate cancer outcomes. Further studies with strict and uniform criteria are encouraged to clarify the association between metabolic syndrome and prostate cancer outcomes.

PROSTATE (2022)

Article Oncology

High expression of Sterol-O-Acyl transferase 1 (SOAT1), an enzyme involved in cholesterol metabolism, is associated with earlier biochemical recurrence in high risk prostate cancer

Carolin Eckhardt et al.

Summary: In high-risk prostate cancer patients, high SOAT1 expression is strongly associated with shorter BCR-free survival, while SOAT2 expression is not significant. High SOAT1 expression remains significantly associated with shorter BCR-free survival after multivariable adjustment, suggesting SOAT1 may serve as a histologic marker of prognosis and a potential treatment target in the future.

PROSTATE CANCER AND PROSTATIC DISEASES (2022)

Review Obstetrics & Gynecology

Endometriosis recurrence following post-operative hormonal suppression: a systematic review and meta-analysis

Andrew Zakhari et al.

Summary: The study shows that post-operative hormonal suppression can significantly reduce the risk of endometriosis recurrence and alleviate associated pain. Various hormonal agents have been effective in preventing recurrence, and treatment should be tailored to each individual's needs.

HUMAN REPRODUCTION UPDATE (2021)

Article Cell Biology

LDL cholesterol promotes the proliferation of prostate and pancreatic cancer cells by activating the STAT3 pathway

Young Yun Jung et al.

Summary: Hypercholesterolemia is closely linked with increased cancer incidence and mortality, and LDL-induced STAT3 activation may have a profound impact on the proliferation and survival of prostate and pancreatic tumor cells.

JOURNAL OF CELLULAR PHYSIOLOGY (2021)

Review Urology & Nephrology

EAU-EANM-ESTRO-ESUR-SIOG Guidelines on Prostate Cancer-2020 Update. Part 1: Screening, Diagnosis, and Local Treatment with Curative Intent

Nicolas Mottet et al.

Summary: The 2020 EAU-EANM-ESTRO-ESUR-SIOG guidelines on screening, diagnosis, and treatment of localized prostate cancer summarize the most recent recommendations for clinical practice, including risk-adapted strategies, medical imaging utilization, biopsy techniques, patient classification, and treatment options. Recommendations include consideration of moderate hypofractionation for intermediate-risk patients and a combination of local treatment with long-term hormonal therapy for cN1 PCa patients.

EUROPEAN UROLOGY (2021)

Article Oncology

Statin use and risk of prostate cancer biochemical recurrence after radical prostatectomy

Nicole Prabhu et al.

Summary: The study in a large surgical cohort found that statin use can improve biochemical recurrence-free survival in prostate cancer patients who have undergone radical prostatectomy, but it does not affect overall survival.

UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2021)

Article Urology & Nephrology

Impact of statin use on overall and time to biochemical failure following radical prostatectomy or radiation therapy

Linda My Huynh et al.

Summary: This study evaluated the impact of statin use on prostate cancer recurrence in patients undergoing RP or RT. While statin use was not associated with reduced risk of BF, it was linked to a shorter time to BF in those patients who experienced recurrence. Further research is needed to clarify the effects of statin use on PCa recurrence.

WORLD JOURNAL OF UROLOGY (2021)

Article Endocrinology & Metabolism

Statin Use and Benefits of Thyroid Function: A Retrospective Cohort Study

Yupeng Wang et al.

Summary: This study aimed to assess the association between statin use and thyroid function, and found that statin use was associated with lower thyroid-stimulating hormone levels and improved thyroid function. Changes in total cholesterol served as a mediator of the association between statin use and thyroid-stimulating hormone levels.

FRONTIERS IN ENDOCRINOLOGY (2021)

Article Oncology

Adjuvant Low-dose Statin Use after Radical Prostatectomy: The PRO-STAT Randomized Clinical Trial

In Gab Jeong et al.

Summary: The study aimed to evaluate the efficacy of adjuvant atorvastatin in high-risk prostate cancer patients after radical prostatectomy. However, the results showed that 1-year adjuvant use of atorvastatin did not reduce the risk of disease recurrence compared to placebo in this patient population.

CLINICAL CANCER RESEARCH (2021)

Article Oncology

Prostate cancer prognosis after initiation of androgen deprivation therapy among statin users. A population-based cohort study

A. I. Peltomaa et al.

Summary: Statins have been found to improve the prognosis of prostate cancer patients undergoing androgen deprivation therapy, but only when used after the initiation of ADT, not before.

PROSTATE CANCER AND PROSTATIC DISEASES (2021)

Article Medicine, General & Internal

The PRISMA 2020 statement: an updated guideline for reporting systematic reviews

Matthew J. Page et al.

SYSTEMATIC REVIEWS (2021)

Article Medicine, General & Internal

Atorvastatin induces adrenal androgen downshift in men with prostate cancer: A post Hoc analysis of a pilot adaptive Randomised clinical trial

Paavo V. H. Raittinen et al.

Summary: The study investigated the impact of atorvastatin on steroid profiles in the serum and prostatic tissue of men with prostate cancer. The findings suggest that atorvastatin may influence adrenal androgen levels in the serum and possibly in the prostate, indicating a potential for improving androgen deprivation therapy efficacy.

EBIOMEDICINE (2021)

Article Cardiac & Cardiovascular Systems

Secondary prevention of cardiovascular disease in China

Jiapeng Lu et al.

HEART (2020)

Review Biochemistry & Molecular Biology

Cholesterol and beyond - The role of the mevalonate pathway in cancer biology

Andy Goebel et al.

BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER (2020)

Article Hematology

Statin use and the risk of multiple myeloma: a PRISMA-compliant meta-analysis

Pengcheng Zhang et al.

ANNALS OF HEMATOLOGY (2020)

Article Medicine, Research & Experimental

Clinical factors affecting prostate-specific antigen levels in prostate cancer patients undergoing radical prostatectomy: a retrospective study

Giovanni Tarantino et al.

Summary: A retrospective study found that PSA levels in male prostate cancer patients were not associated with BMI, history of chronic obstructive pulmonary disease, or heavy drinking, but were associated with smoking status.

FUTURE SCIENCE OA (2020)

Editorial Material Andrology

Statins and Erectile Dysfunction

John B. Kostis et al.

WORLD JOURNAL OF MENS HEALTH (2019)

Article Public, Environmental & Occupational Health

Trends and age-period-cohort effect on incidence and mortality of prostate cancer from 1990 to 2017 in China

X. Liu et al.

PUBLIC HEALTH (2019)

Editorial Material Medical Laboratory Technology

Metabolic Factors and Prostate Cancer Risk

Barbra Dickerman et al.

CLINICAL CHEMISTRY (2019)

Article Cell Biology

Mechanical cues control mutant p53 stability through a mevalonate-RhoA axis

Eleonora Ingallina et al.

NATURE CELL BIOLOGY (2018)

Article Endocrinology & Metabolism

Statin use, high cholesterol and prostate cancer progression; results from HCaP-NC

Emma H. Allott et al.

PROSTATE (2018)

Article Oncology

Statin use and time to progression in men on active surveillance for prostate cancer

Viranda H. Jayalath et al.

PROSTATE CANCER AND PROSTATIC DISEASES (2018)

Article Medicine, Research & Experimental

The Epidemiology of Prostate Cancer

Claire H. Pernar et al.

COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2018)

Article Pharmacology & Pharmacy

Simvastatin Sensitizes Radioresistant Prostate Cancer Cells by Compromising DNA Double-Strand Break Repair

Yu-An Chen et al.

FRONTIERS IN PHARMACOLOGY (2018)

Review Urology & Nephrology

The current evidence on statin use and prostate cancer prevention: are we there yet?

Mahmoud A. Alfaqih et al.

NATURE REVIEWS UROLOGY (2017)

Review Oncology

Clinical Potential of Statins in Prostate Cancer Radiation Therapy

Jack Hutchinson et al.

ANTICANCER RESEARCH (2017)

Article Endocrinology & Metabolism

Statin use and risk of disease recurrence and death after radical prostatectomy

Teemu Keskivali et al.

PROSTATE (2016)

Article Biochemistry & Molecular Biology

Additive inhibitory effects of simvastatin and enzalutamide on androgen-sensitive LNCaP and VCaP prostate cancer cells

Heimo Syvala et al.

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2016)

Article Urology & Nephrology

Statin use is associated with decreased prostate cancer recurrence in men treated with brachytherapy

Daniel S. Oh et al.

WORLD JOURNAL OF UROLOGY (2015)

Article Oncology

Serum Lipid Profile and Risk of Prostate Cancer Recurrence: Results from the SEARCH Database

Emma H. Allott et al.

CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2014)

Article Endocrinology & Metabolism

Statin Use in Relation to Prostate Cancer Outcomes in a Population-based Patient Cohort Study

Milan S. Geybels et al.

PROSTATE (2013)

Article Oncology

Impact of statin use on biochemical recurrence in patients treated with radical prostatectomy

M. Rieken et al.

PROSTATE CANCER AND PROSTATIC DISEASES (2013)

Article Pharmacology & Pharmacy

Cholesterol and prostate cancer

Kristine Pelton et al.

CURRENT OPINION IN PHARMACOLOGY (2012)

Article Oncology

Aspirin and Statin Nonuse Associated With Early Biochemical Failure After Prostate Radiation Therapy

Nicholas G. Zaorsky et al.

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2012)

Article Oncology

IMPROVED BIOCHEMICAL OUTCOMES WITH STATIN USE IN PATIENTS WITH HIGH-RISK LOCALIZED PROSTATE CANCER TREATED WITH RADIOTHERAPY

Marisa A. Kollmeier et al.

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2011)

Article Oncology

Statin Use and Risk of Prostate Cancer Recurrence in Men Treated With Radiation Therapy

Ruchika Gutt et al.

JOURNAL OF CLINICAL ONCOLOGY (2010)

Meeting Abstract Urology & Nephrology

IMPACT OF STATIN USE ON PATHOLOGIC FEATURES IN MEN TREATED WITH RADICAL PROSTATECTOMY

Jorge Rioja et al.

JOURNAL OF UROLOGY (2010)

Article Cell Biology

SREBP activity is regulated by mTORC1 and contributes to Akt-dependent cell growth

Thomas Porstmann et al.

CELL METABOLISM (2008)

Review Biotechnology & Applied Microbiology

Post-translational modifications and regulation of the RAS superfamily of GTPases as anticancer targets

Panagiotis A. Konstantinopoulos et al.

NATURE REVIEWS DRUG DISCOVERY (2007)

Meeting Abstract Oncology

Statin use and clinical outcomes after high dose radiotherapy for prostate cancer

A. M. Shippy et al.

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2007)

Article Oncology

Statin drugs and risk of advanced prostate cancer

Elizabeth A. Platz et al.

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2006)

Meeting Abstract Oncology

Statin use prior to radiation therapy for prostate cancer does not improve outcome: The Fox Chase experience

N. K. Sharma et al.

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2006)

Article Public, Environmental & Occupational Health

Statins and prostate cancer risk: A case-control study

J Shannon et al.

AMERICAN JOURNAL OF EPIDEMIOLOGY (2005)

Review Endocrinology & Metabolism

Membrane rafts as potential sites of nongenomic hormonal signaling in prostate cancer

MR Freeman et al.

TRENDS IN ENDOCRINOLOGY AND METABOLISM (2005)

Article Medicine, General & Internal

Statins and the risk of colorectal cancer

JN Poynter et al.

NEW ENGLAND JOURNAL OF MEDICINE (2005)

Article Oncology

The risk of cancer in users of statins

MR Graaf et al.

JOURNAL OF CLINICAL ONCOLOGY (2004)